{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:01:12Z","timestamp":1790611272736,"version":"4.1.0"},"reference-count":282,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005408","name":"University of Electronic Science and Technology of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005408","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2020.560375","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T05:56:51Z","timestamp":1604555811000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":107,"title":["Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review"],"prefix":"10.3389","volume":"11","author":[{"given":"Jorge","family":"Berlanga-Acosta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Guill\u00e9n-Nieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Rodr\u00edguez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Bringas-Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Garc\u00eda-del-Barco-Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge O.","family":"Berlanga-Saez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariana","family":"Garc\u00eda-Ojalvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell Joseph","family":"Vald\u00e9s-Sosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro A.","family":"Vald\u00e9s-Sosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0079-6123(06)53007-9","article-title":"The selfish brain: competition for energy resources","volume":"153","author":"Fehm","year":"2006","journal-title":"Prog Brain Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3389\/fphys.2019.00457","article-title":"Is the brain a key player in glucose regulation and development of type 2 diabetes?","volume":"10","author":"Lundqvist","year":"2019","journal-title":"Front Physiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.tins.2013.07.001","article-title":"Sugar for the brain: the role of glucose in physiological and pathological brain function","volume":"36","author":"Mergenthaler","year":"2013","journal-title":"Trends Neurosci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s00702-017-1763-2","article-title":"The diabetic brain and cognition","volume":"124","author":"Riederer","year":"2017","journal-title":"J Neural Transm."},{"key":"B5","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1515\/hsz-2018-0135","article-title":"Insulin-like signaling within and beyond metazoans","volume":"399","author":"Vitali","year":"2018","journal-title":"Biol Chem."},{"key":"B6","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.neuropharm.2017.09.016","article-title":"Reduced brain insulin signaling: a seminal process in Alzheimer's disease pathogenesis","volume":"136","author":"Bloom","year":"2018","journal-title":"Neuropharmacology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1016\/j.jalz.2014.02.001","article-title":"Alzheimer's disease facts and figures","volume":"10","author":"Alzheimer's","year":"2014","journal-title":"Alzheimers Dement"},{"key":"B8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s40265-016-0674-0","article-title":"Insulin resistance and neurodegeneration: progress towards the development of new therapeutics for Alzheimer's disease","volume":"77","author":"de la Monte","year":"2017","journal-title":"Drugs."},{"key":"B9","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1172\/JCI64595","article-title":"Alzheimer's disease and insulin resistance: translating basic science into clinical applications","volume":"123","author":"De Felice","year":"2013","journal-title":"J Clin Invest."},{"key":"B10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev-med-042915-103753","article-title":"Update on Alzheimer's disease therapy and prevention strategies","volume":"68","author":"Graham","year":"2017","journal-title":"Annu Rev Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1212\/CON.0000000000000687","article-title":"Early-onset Alzheimer disease and its variants","volume":"25","author":"Mendez","year":"2019","journal-title":"Continuum."},{"key":"B12","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1515\/revneuro-2017-0006","article-title":"Alzheimer's disease: as it was in the beginning","volume":"28","author":"Kozlov","year":"2017","journal-title":"Rev Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1212\/CON.0000000000000307","article-title":"Alzheimer disease","volume":"22","author":"Apostolova","year":"2016","journal-title":"Continuum."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1016\/S0140-6736(12)60360-2","article-title":"Diabetes and cognitive dysfunction","volume":"379","author":"McCrimmon","year":"2012","journal-title":"Lancet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.amjmed.2014.08.025","article-title":"Glycemia and cognitive function in metabolic syndrome and coronary heart disease","volume":"128","author":"Avadhani","year":"2015","journal-title":"Am J Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.bbadis.2016.04.017","article-title":"Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease","volume":"1863","author":"Pugazhenthi","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.dsx.2018.05.003","article-title":"Thinking about brain insulin resistance","volume":"12","author":"Al Haj Ahmad","year":"2018","journal-title":"Diabetes Metab Syndr."},{"key":"B18","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.bcp.2013.12.012","article-title":"Brain metabolic dysfunction at the core of Alzheimer's disease","volume":"88","author":"de la Monte","year":"2014","journal-title":"Biochem Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.mad.2019.03.008","article-title":"Crucial players in Alzheimer's disease and diabetes mellitus: friends or foes?","volume":"181","author":"Kubis-Kubiak","year":"2019","journal-title":"Mech Ageing Dev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/978-1-4614-0653-2_19","article-title":"Neurodegeneration in diabetes mellitus","volume":"724","author":"Umegaki","year":"2012","journal-title":"Adv Exp Med Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/jdi.12087","article-title":"Diabetes mellitus and risk of dementia: a meta-analysis of prospective observational studies","volume":"4","author":"Gudala","year":"2013","journal-title":"J Diabetes Investig."},{"key":"B22","doi-asserted-by":"publisher","first-page":"666545","DOI":"10.1101\/666545","article-title":"miR-467 prevents inflammation and insulin resistance in response to hyperglycemia","author":"Gajeton","year":"2019","journal-title":"bioRxiv [Preprint]"},{"key":"B23","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.cmet.2017.06.010","article-title":"Insulin regulation of proteostasis and clinical implications","volume":"26","author":"James","year":"2017","journal-title":"Cell Metab."},{"key":"B24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev.physiol.68.040104.124723","article-title":"From mice to men: insights into the insulin resistance syndromes","volume":"68","author":"Biddinger","year":"2006","journal-title":"Annu Rev Physiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1172\/JCI10582","article-title":"Signaling pathways in insulin action: molecular targets of insulin resistance","volume":"106","author":"Pessin","year":"2000","journal-title":"J Clin Invest."},{"key":"B26","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12862-017-0994-z","article-title":"Evolution of the vertebrate insulin receptor substrate (Irs) gene family","volume":"17","author":"Al-Salam","year":"2017","journal-title":"BMC Evolut Biol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jcjd.2016.07.002","article-title":"Insulin signalling: the inside story","volume":"41","author":"Posner","year":"2017","journal-title":"Can J Diabet."},{"key":"B28","first-page":"19","article-title":"Insulin and insulin resistance","volume":"26","author":"Wilcox","year":"2005","journal-title":"Clin Biochem Rev."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.3390\/ijms19113306","article-title":"Type 2 diabetes mellitus and Alzheimer's disease: role of insulin signalling and therapeutic implications","volume":"19","author":"Tumminia","year":"2018","journal-title":"Int J Mol Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/nan.12476","article-title":"Review: relationship of type 2 diabetes to human brain pathology","volume":"44","author":"Pruzin","year":"2018","journal-title":"Neuropathol Appl Neurobiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrendo.2014.208","article-title":"Insulin and IGF receptor signalling in neural-stem-cell homeostasis","volume":"11","author":"Ziegler","year":"2015","journal-title":"Nat Rev Endocrinol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.mad.2016.05.005","article-title":"Molecular pathophysiology of impaired glucose metabolism, mitochondrial dysfunction, and oxidative DNA damage in Alzheimer's disease brain","volume":"161","author":"Abolhassani","year":"2017","journal-title":"Mech Ageing Dev."},{"key":"B33","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3390\/ijms20040941","article-title":"Metabolic plasticity of astrocytes and aging of the brain","volume":"20","author":"Morita","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1007\/s00125-012-2644-8","article-title":"Regulation of insulin sensitivity by serine\/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2","volume":"55","author":"Copps","year":"2012","journal-title":"Diabetologia."},{"key":"B35","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","article-title":"Mechanisms for insulin resistance: common threads and missing links","volume":"148","author":"Samuel","year":"2012","journal-title":"Cell."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.3233\/JAD-160841","article-title":"Glucose transporters in brain: in health and in Alzheimer's disease","volume":"55","author":"Szablewski","year":"2017","journal-title":"J Alzheimers Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1073\/pnas.0308724101","article-title":"Role for neuronal insulin resistance in neurodegenerative diseases","volume":"101","author":"Schubert","year":"2004","journal-title":"Proc Natl Acad Sci USA."},{"key":"B38","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3389\/fendo.2014.00161","article-title":"Insulin in the brain: its pathophysiological implications for states related with central insulin resistance, type 2 diabetes and Alzheimer's disease","volume":"5","author":"Bl\u00e1zquez","year":"2014","journal-title":"Front Endocrinol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1507\/endocrj.EJ15-0540","article-title":"Central insulin-mediated regulation of hepatic glucose production [Review]","volume":"63","author":"Inoue","year":"2016","journal-title":"Endocr J."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.15252\/embj.201695810","article-title":"Brain metabolism in health, aging, and neurodegeneration","volume":"36","author":"Camandola","year":"2017","journal-title":"EMBO J."},{"key":"B41","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S0166-2236(03)00163-2","article-title":"Potential roles of insulin and IGF-1 in Alzheimer's disease","volume":"26","author":"Gasparini","year":"2003","journal-title":"Trends Neurosci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"T171","DOI":"10.1530\/JME-18-0093","article-title":"40 YEARS of IGF1: IGF1: the jekyll and Hyde of the aging brain","volume":"61","author":"Gubbi","year":"2018","journal-title":"J Mol Endocrinol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.neurobiolaging.2008.04.002","article-title":"Defects in IGF-1 receptor, insulin receptor and IRS-1\/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling","volume":"31","author":"Moloney","year":"2010","journal-title":"Neurobiol Aging."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1212\/WNL.0000000000000382","article-title":"Insulin-like growth factor-1 and risk of alzheimer dementia and brain atrophy","volume":"82","author":"Westwood","year":"2014","journal-title":"Neurology."},{"key":"B45","doi-asserted-by":"publisher","first-page":"356","DOI":"10.2174\/157339911797415594","article-title":"Central insulin and insulin-like growth factor-1 signaling: implications for diabetes associated dementia","volume":"7","author":"Zemva","year":"2011","journal-title":"Curr Diabetes Rev."},{"key":"B46","doi-asserted-by":"publisher","first-page":"416","DOI":"10.23736\/S0390-5616.16.03431-7","article-title":"IGF-1: an endogenous link between traumatic brain injury and alzheimer disease?","volume":"61","author":"Zheng","year":"2017","journal-title":"J Neurosurg Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1111\/j.1471-4159.2005.03155.x","article-title":"A biochemical and functional characterization of diet-induced brain insulin resistance","volume":"93","author":"Mielke","year":"2005","journal-title":"J Neurochem."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1084\/jem.20160493","article-title":"Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?","volume":"213","author":"Stanley","year":"2016","journal-title":"J Exp Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3233\/JAD-2009-0972","article-title":"An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease","volume":"16","author":"Moreira","year":"2009","journal-title":"J Alzheimers Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3233\/JAD-2005-8304","article-title":"Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine","volume":"8","author":"Rivera","year":"2005","journal-title":"J Alzheimers Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease\u2013is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"J Alzheimers Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1749-6632.1999.tb07839.x","article-title":"A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer's disease","volume":"893","author":"Frolich","year":"1999","journal-title":"Ann N Y Acad Sci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ejphar.2004.02.048","article-title":"Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease","volume":"490","author":"Watson","year":"2004","journal-title":"Eur J Pharmacol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.bbadis.2016.08.018","article-title":"Is Alzheimer's disease a type 3 diabetes? A critical appraisal","volume":"1863","author":"Kandimalla","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1212\/01.WNL.0000140292.04932.87","article-title":"Hyperinsulinemia and risk of alzheimer disease","volume":"63","author":"Luchsinger","year":"2004","journal-title":"Neurology."},{"key":"B56","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/0736-5748(94)90053-1","article-title":"Intracerebroventricular injection of streptozotocin induces discrete local changes in cerebral glucose utilization in rats","volume":"12","author":"Duelli","year":"1994","journal-title":"Int J Dev Neurosci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.bbadis.2013.09.010","article-title":"The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives","volume":"1842","author":"Swerdlow","year":"2014","journal-title":"Biochim Biophys Acta."},{"key":"B58","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.nbd.2014.05.001","article-title":"Early detection of Alzheimer's disease using PiB and FDG PET","volume":"72","author":"Cohen","year":"2014","journal-title":"Neurobiol Dis."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.bbadis.2011.08.005","article-title":"Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: implications for early intervention and therapeutics","volume":"1812","author":"Mao","year":"2011","journal-title":"Biochim Biophys Acta."},{"key":"B60","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1212\/WNL.0000000000006745","article-title":"Translating the biology of aging into novel therapeutics for alzheimer disease","volume":"92","author":"Hara","year":"2019","journal-title":"Neurology."},{"key":"B61","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nrneurol.2015.251","article-title":"Suspected non-alzheimer disease pathophysiology\u2013concept and controversy","volume":"12","author":"Jack","year":"2016","journal-title":"Nat Rev Neurol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2174\/1568008054064869","article-title":"Myocardial insulin resistance and cardiac complications of diabetes","volume":"5","author":"Abel","year":"2005","journal-title":"Curr Drug Targets Immune Endocr Metabol Disord."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1016\/j.bbadis.2017.02.019","article-title":"The biochemical alterations underlying post-burn hypermetabolism","volume":"1863","author":"Auger","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"key":"B64","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.2337\/dbi15-0011","article-title":"A key role of insulin receptors in memory","volume":"64","author":"De Felice","year":"2015","journal-title":"Diabetes."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1177\/193229680800200619","article-title":"Alzheimer's disease is type 3 diabetes-evidence reviewed","volume":"2","author":"de la Monte","year":"2008","journal-title":"J Diabetes Sci Technol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"751","DOI":"10.2337\/dc16-2001","article-title":"Insulin resistance predicts cognitive decline: an 11-year follow-up of a nationally representative adult population sample","volume":"40","author":"Ekblad","year":"2017","journal-title":"Diabetes Care."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1152\/physrev.00032.2015","article-title":"Brain insulin resistance at the crossroads of metabolic and cognitive disorders in humans","volume":"96","author":"Kullmann","year":"2016","journal-title":"Physiol Rev."},{"key":"B68","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cca.2015.01.027","article-title":"Insulin resistance and cognitive dysfunction","volume":"444","author":"Ma","year":"2015","journal-title":"Clin Chim Acta."},{"key":"B69","doi-asserted-by":"publisher","first-page":"105828","DOI":"10.1155\/2015\/105828","article-title":"Inflammation and oxidative stress: the molecular connectivity between insulin resistance, obesity, and Alzheimer's disease","volume":"2015","author":"Verdile","year":"2015","journal-title":"Mediators Inflamm."},{"key":"B70","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1523\/JNEUROSCI.22-09-03376.2002","article-title":"Activation of c-Jun N-terminal kinase and p38 in an Alzheimer's disease model is associated with amyloid deposition","volume":"22","author":"Savage","year":"2002","journal-title":"J Neurosci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3389\/fphar.2015.00321","article-title":"c-Jun N-terminal kinase (JNK) signaling as a therapeutic target for Alzheimer's disease","volume":"6","author":"Yarza","year":"2015","journal-title":"Front Pharmacol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.3233\/JAD-190808","article-title":"Hyperinsulinemia or insulin resistance: what impacts the progression of Alzheimer's disease?","volume":"72","author":"Hegde","year":"2019","journal-title":"J Alzheimers Dis."},{"key":"B73","doi-asserted-by":"publisher","first-page":"S262","DOI":"10.2337\/dc08-s264","article-title":"Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse?","volume":"31","author":"Shanik","year":"2008","journal-title":"Diabetes Care."},{"key":"B74","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1073\/pnas.71.1.84","article-title":"Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture","volume":"71","author":"Gavin","year":"1974","journal-title":"Proc Natl Acad Sci USA."},{"key":"B75","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1210\/er.2017-00073","article-title":"Insulin receptor isoforms in physiology and disease: an updated view","volume":"38","author":"Belfiore","year":"2017","journal-title":"Endocr Rev."},{"key":"B76","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1159\/000455865","article-title":"Hypothalamic insulin resistance in obesity: effects on glucose homeostasis","volume":"104","author":"Chen","year":"2017","journal-title":"Neuroendocrinology."},{"key":"B77","doi-asserted-by":"publisher","first-page":"39723","DOI":"10.1074\/jbc.M508824200","article-title":"Physiological and pathological changes in glucose regulate brain Akt and glycogen synthase kinase-3","volume":"280","author":"Clodfelder-Miller","year":"2005","journal-title":"J Biol Chem."},{"key":"B78","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nature01640","article-title":"GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides","volume":"423","author":"Phiel","year":"2003","journal-title":"Nature."},{"key":"B79","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/iub.1098","article-title":"The impairment of insulin signaling in Alzheimer's disease","volume":"64","author":"Candeias","year":"2012","journal-title":"IUBMB Life."},{"key":"B80","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","article-title":"Oxidative stress, dysfunctional glucose metabolism and alzheimer disease","volume":"20","author":"Butterfield","year":"2019","journal-title":"Nat Rev Neurosci."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/alzrt59","article-title":"Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease","volume":"3","author":"Bateman","year":"2011","journal-title":"Alzheimers Res Ther."},{"key":"B82","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.arr.2011.01.001","article-title":"Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease?","volume":"10","author":"Correia","year":"2011","journal-title":"Ageing Res Rev."},{"key":"B83","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.1007\/s12035-015-9384-y","article-title":"Streptozotocin intracerebroventricular-induced neurotoxicity and brain insulin resistance: a therapeutic intervention for treatment of sporadic Alzheimer's disease (sAD)-like pathology","volume":"53","author":"Kamat","year":"2016","journal-title":"Mol Neurobiol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"613","DOI":"10.14348\/molcells.2017.0096","article-title":"Molecular and cellular basis of neurodegeneration in Alzheimer's disease","volume":"40","author":"Jeong","year":"2017","journal-title":"Mol Cells."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.4239\/wjd.v6.i12.1223","article-title":"Molecular and biochemical trajectories from diabetes to Alzheimer's disease: a critical appraisal","volume":"6","author":"Sandhir","year":"2015","journal-title":"World J Diabetes."},{"key":"B86","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00125-014-3462-y","article-title":"Epigenetic mechanisms in diabetic complications and metabolic memory","volume":"58","author":"Reddy","year":"2015","journal-title":"Diabetologia."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/j.bcp.2010.06.005","article-title":"Glycemic memory associated epigenetic changes","volume":"80","author":"Siebel","year":"2010","journal-title":"Biochem Pharmacol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"830","DOI":"10.3389\/fnins.2018.00830","article-title":"Insulin resistance in Alzheimer's disease","volume":"12","author":"Ferreira","year":"2018","journal-title":"Front Neurosci."},{"key":"B89","doi-asserted-by":"publisher","first-page":"50","DOI":"10.15420\/ecr.2018.33.1","article-title":"The role of inflammation in diabetes: current concepts and future perspectives","volume":"14","author":"Tsalamandris","year":"2019","journal-title":"Eur Cardiol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.2337\/db13-1954","article-title":"Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to alzheimer disease","volume":"63","author":"De Felice","year":"2014","journal-title":"Diabetes."},{"key":"B91","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s10787-019-00580-x","article-title":"Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer's disease","volume":"27","author":"Kaur","year":"2019","journal-title":"Inflammopharmacology."},{"key":"B92","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s12035-018-1092-y","article-title":"Could Alzheimer's disease originate in the periphery and if so how so?","volume":"56","author":"Morris","year":"2019","journal-title":"Mol Neurobiol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1742-2094-2-9","article-title":"Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease","volume":"2","author":"Patel","year":"2005","journal-title":"J Neuroinflammation."},{"key":"B94","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2174\/1389450043345308","article-title":"Cytokines in neuroinflammation and Alzheimer's disease","volume":"5","author":"Cacquevel","year":"2004","journal-title":"Curr Drug Targets."},{"key":"B95","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/978-3-211-73574-9_28","article-title":"Central insulin resistance as a trigger for sporadic alzheimer-like pathology: an experimental approach","volume":"72","author":"Salkovic-Petrisic","year":"2007","journal-title":"J Neural Transm Suppl"},{"key":"B96","doi-asserted-by":"publisher","first-page":"109884","DOI":"10.1016\/j.pnpbp.2020.109884","article-title":"New mechanism of neuroinflammation in Alzheimer's disease: the activation of NLRP3 inflammasome mediated by gut microbiota","volume":"100","author":"Shen","year":"2020","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"B97","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3233\/JAD-170929","article-title":"Alzheimer's disease: recent concepts on the relation of mitochondrial disturbances, excitotoxicity, neuroinflammation, and kynurenines","volume":"62","author":"Zadori","year":"2018","journal-title":"J Alzheimers Dis."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1126\/science.1110647","article-title":"Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo","volume":"308","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A unique microglia type associated with restricting development of Alzheimer's disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41598-018-19699-y","article-title":"Innate immune alterations are elicited in microglial cells before plaque deposition in the Alzheimer's disease mouse model 5xFAD","volume":"8","author":"Boza-Serrano","year":"2018","journal-title":"Sci Rep."},{"key":"B101","doi-asserted-by":"publisher","first-page":"8845","DOI":"10.1523\/JNEUROSCI.4027-13.2014","article-title":"Ear2 deletion causes early memory and learning deficits in APP\/PS1 mice","volume":"34","author":"Kummer","year":"2014","journal-title":"J Neurosci."},{"key":"B102","doi-asserted-by":"publisher","first-page":"e15176","DOI":"10.1371\/journal.pone.0015176","article-title":"Mathematical modeling for the pathogenesis of Alzheimer's disease","volume":"5","author":"Puri","year":"2010","journal-title":"PLoS ONE."},{"key":"B103","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/ni.1836","article-title":"CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer","volume":"11","author":"Stewart","year":"2010","journal-title":"Nat Immunol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1159\/000110455","article-title":"Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease","volume":"20","author":"Walter","year":"2007","journal-title":"Cell Physiol Biochem."},{"key":"B105","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.expneurol.2012.10.007","article-title":"Astrocytes: conductors of the alzheimer disease neuroinflammatory symphony","volume":"239","author":"Medeiros","year":"2013","journal-title":"Exp Neurol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/glia.20967","article-title":"Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease","volume":"58","author":"Olabarria","year":"2010","journal-title":"Glia."},{"key":"B107","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature."},{"key":"B108","doi-asserted-by":"publisher","first-page":"7918","DOI":"10.1074\/jbc.275.11.7918","article-title":"Beta-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1beta- and tumor necrosis factor-alpha (TNFalpha)-dependent, and involves a TNFalpha receptor-associated factor- and NFkappaB-inducing kinase-dependent signaling mechanism","volume":"275","author":"Akama","year":"2000","journal-title":"J Biol Chem."},{"key":"B109","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S0197-4580(01)00287-1","article-title":"Interleukin-1, neuroinflammation, and Alzheimer's disease","volume":"22","author":"Mrak","year":"2001","journal-title":"Neurobiol Aging."},{"key":"B110","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/0046-8177(95)90001-2","article-title":"Glial cytokines in Alzheimer's disease: review and pathogenic implications","volume":"26","author":"Mrak","year":"1995","journal-title":"Hum Pathol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.ajpath.2011.05.047","article-title":"Reactive glia not only associates with plaques but also parallels tangles in Alzheimer's disease","volume":"179","author":"Serrano-Pozo","year":"2011","journal-title":"Am J Pathol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3389\/fnagi.2019.00271","article-title":"Role of microglial cells in Alzheimer's disease tau propagation","volume":"11","author":"\u0160pani\u0107","year":"2019","journal-title":"Front Aging Neurosci."},{"key":"B113","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41593-018-0332-9","article-title":"Mitophagy inhibits amyloid-beta and tau pathology and reverses cognitive deficits in models of Alzheimer's disease","volume":"22","author":"Fang","year":"2019","journal-title":"Nat Neurosci."},{"key":"B114","doi-asserted-by":"publisher","first-page":"104469","DOI":"10.1016\/j.neuint.2019.104469","article-title":"Microglial mitophagy mitigates neuroinflammation in Alzheimer's disease","volume":"129","author":"Lautrup","year":"2019","journal-title":"Neurochem Int."},{"key":"B115","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature."},{"key":"B116","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3390\/ijms17030338","article-title":"Amyloid-beta and astrocytes interplay in amyloid-beta related disorders","volume":"17","author":"Batarseh","year":"2016","journal-title":"Int J Mol Sci."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1002\/glia.21212","article-title":"Multiple cellular and molecular mechanisms are involved in human A\u03b2 clearance by transplanted adult astrocytes","volume":"59","author":"Pihlaja","year":"2011","journal-title":"Glia."},{"key":"B118","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.expneurol.2012.09.009","article-title":"Environmental enrichment prevents astroglial pathological changes in the hippocampus of APP transgenic mice, model of Alzheimer's disease","volume":"239","author":"Beauquis","year":"2013","journal-title":"Exp Neurol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.arr.2014.07.004","article-title":"When astrocytes become harmful: functional and inflammatory responses that contribute to Alzheimer's disease","volume":"18","author":"Avila-Munoz","year":"2014","journal-title":"Ageing Res Rev."},{"key":"B120","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1152\/physiol.00024.2010","article-title":"Oxidative stress and cell membranes in the pathogenesis of Alzheimer's disease","volume":"26","author":"Axelsen","year":"2011","journal-title":"Physiology."},{"key":"B121","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.jalz.2013.12.004","article-title":"How does brain insulin resistance develop in Alzheimer's disease?","volume":"10","author":"De Felice","year":"2014","journal-title":"Alzheimer's Dementia."},{"key":"B122","doi-asserted-by":"publisher","first-page":"9078","DOI":"10.1523\/JNEUROSCI.1071-09.2009","article-title":"Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin","volume":"29","author":"Ma","year":"2009","journal-title":"J Neurosci."},{"key":"B123","doi-asserted-by":"publisher","first-page":"190","DOI":"10.15252\/emmm.201404183","article-title":"Alzheimer-associated A\u03b2 oligomers impact the central nervous system to induce peripheral metabolic deregulation","volume":"7","author":"Clarke","year":"2015","journal-title":"EMBO Mol Med."},{"key":"B124","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/path.5056","article-title":"The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease","volume":"245","author":"Batista","year":"2018","journal-title":"J Pathol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1172\/JCI57256","article-title":"An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated A\u03b2 oligomers","volume":"122","author":"Bomfim","year":"2012","journal-title":"J Clin Invest."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1073\/pnas.0809158106","article-title":"Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of A\u03b2 oligomers","volume":"106","author":"De Felice","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B127","doi-asserted-by":"publisher","first-page":"33305","DOI":"10.1074\/jbc.M610390200","article-title":"Soluble A\u03b2 inhibits specific signal transduction cascades common to the insulin receptor pathway","volume":"282","author":"Townsend","year":"2007","journal-title":"J Biol Chem."},{"key":"B128","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1126\/science.271.5249.665","article-title":"IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance","volume":"271","author":"Hotamisligil","year":"1996","journal-title":"Science."},{"key":"B129","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.2337\/db14-0287","article-title":"Repurposing diabetes drugs for brain insulin resistance in alzheimer disease","volume":"63","author":"Yarchoan","year":"2014","journal-title":"Diabetes."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.4103\/1673-5374.253535","article-title":"Involvement of insulin receptor substrates in cognitive impairment and Alzheimer's disease","volume":"14","author":"Tanokashira","year":"2019","journal-title":"Neural Regen Res."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1001\/archneur.62.11.1734","article-title":"Circulating levels of soluble receptor for advanced glycation end products in alzheimer disease and vascular dementia","volume":"62","author":"Emanuele","year":"2005","journal-title":"Arch Neurol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s10571-015-0233-3","article-title":"Role of RAGE in Alzheimer's disease","volume":"36","author":"Cai","year":"2016","journal-title":"Cell Mol Neurobiol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1006\/exnr.2001.7732","article-title":"Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism","volume":"171","author":"Lue","year":"2001","journal-title":"Exp Neurol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s00702-008-0069-9","article-title":"Decreased plasma levels of soluble receptor for advanced glycation end products in mild cognitive impairment","volume":"115","author":"Ghidoni","year":"2008","journal-title":"J Neural Transm."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1134\/S0006297918090079","article-title":"Anti-amyloid therapy of Alzheimer's disease: current state and prospects","volume":"83","author":"Kozin","year":"2018","journal-title":"Biochemistry."},{"key":"B136","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s40120-017-0074-8","article-title":"Amyloid beta and tau as Alzheimer's disease blood biomarkers: promise from new technologies","volume":"6","author":"Lue","year":"2017","journal-title":"Neurol Ther."},{"key":"B137","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3233\/JAD-160612","article-title":"Amyloid-beta and phosphorylated tau accumulations cause abnormalities at synapses of Alzheimer's disease neurons","volume":"57","author":"Rajmohan","year":"2017","journal-title":"J Alzheimers Dis."},{"key":"B138","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1750-1326-9-51","article-title":"Models of beta-amyloid induced tau-pathology: the long and \u201cfolded\u201d road to understand the mechanism","volume":"9","author":"Stancu","year":"2014","journal-title":"Mol Neurodegener."},{"key":"B139","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1755-5949.2010.00221.x","article-title":"The upside of APP at synapses","volume":"18","author":"Hoe","year":"2012","journal-title":"CNS Neurosci Ther."},{"key":"B140","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","article-title":"Oxidative stress and the amyloid beta peptide in Alzheimer's disease","volume":"14","author":"Cheignon","year":"2018","journal-title":"Redox Biol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1756-6606-5-25","article-title":"Alzheimer's disease A\u03b2 assemblies mediating rapid disruption of synaptic plasticity and memory","volume":"5","author":"Klyubin","year":"2012","journal-title":"Mol Brain."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1096\/fj.09-139634","article-title":"RAGE-dependent signaling in microglia contributes to neuroinflammation, A\u03b2 accumulation, and impaired learning\/memory in a mouse model of Alzheimer's disease","volume":"24","author":"Fang","year":"2010","journal-title":"FASEB J."},{"key":"B143","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1523\/JNEUROSCI.1136-17.2017","article-title":"Microglia-mediated synapse loss in Alzheimer's disease","volume":"38","author":"Rajendran","year":"2018","journal-title":"J Neurosci."},{"key":"B144","doi-asserted-by":"publisher","first-page":"118664","DOI":"10.1016\/j.bbamcr.2020.118664","article-title":"Glycogen synthase kinase-3 signaling in Alzheimer's disease","volume":"1867","author":"Lauretti","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Res."},{"key":"B145","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bbr.2017.11.015","article-title":"Diabetes mellitus and Alzheimer's disease: GSK-3beta as a potential link","volume":"339","author":"Zhang","year":"2018","journal-title":"Behav Brain Res."},{"key":"B146","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.neurobiolaging.2005.01.004","article-title":"Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis","volume":"27","author":"Qiu","year":"2006","journal-title":"Neurobiol Aging."},{"key":"B147","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0002-9440(10)63822-9","article-title":"Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele","volume":"162","author":"Cook","year":"2003","journal-title":"Am J Pathol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00401-018-1868-1","article-title":"Alzheimer's disease pathology propagation by exosomes containing toxic amyloid-beta oligomers","volume":"136","author":"Sardar Sinha","year":"2018","journal-title":"Acta Neuropathol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00125-016-3873-z","article-title":"Multiple benefits of targeting inflammation in the treatment of type 2 diabetes","volume":"59","author":"Donath","year":"2016","journal-title":"Diabetologia."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"Lopez-Otin","year":"2013","journal-title":"Cell."},{"key":"B151","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.2337\/dc05-2327","article-title":"Diabetes, hyperglycemia, and inflammation in older individuals: the health, aging and body composition study","volume":"29","author":"de Rekeneire","year":"2006","journal-title":"Diabetes Care."},{"key":"B152","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11596-017-1732-x","article-title":"Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease","volume":"37","author":"Ma","year":"2017","journal-title":"J Huazhong Univ Sci Technolog Med Sci."},{"key":"B153","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0165-0173(00)00019-9","article-title":"Tau protein isoforms, phosphorylation and role in neurodegenerative disorders","volume":"33","author":"Buee","year":"2000","journal-title":"Brain Res Brain Res Rev."},{"key":"B154","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S0166-2236(00)02031-2","article-title":"Alzheimer's disease-do tauists and baptists finally shake hands?","volume":"25","author":"Mudher","year":"2002","journal-title":"Trends Neurosci."},{"key":"B155","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s12031-018-1111-5","article-title":"Prion-like propagation of post-translationally modified tau in Alzheimer's disease: a hypothesis","volume":"65","author":"Sonawane","year":"2018","journal-title":"J Mol Neurosci."},{"key":"B156","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fncel.2014.00022","article-title":"Insulin dysfunction and Tau pathology","volume":"8","author":"El Khoury","year":"2014","journal-title":"Front Cell Neurosci."},{"key":"B157","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1093\/brain\/awx256","article-title":"Tau hyperphosphorylation induces oligomeric insulin accumulation and insulin resistance in neurons","volume":"140","author":"Rodriguez-Rodriguez","year":"2017","journal-title":"Brain."},{"key":"B158","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.freeradbiomed.2015.02.028","article-title":"Molecular mechanisms linking amyloid beta toxicity and tau hyperphosphorylation in alzheimers disease","volume":"83","author":"Lloret","year":"2015","journal-title":"Free Radic Biol Med."},{"key":"B159","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4103\/0019-5545.44908","article-title":"Neurobiology of Alzheimer's disease","volume":"51","author":"Mohandas","year":"2009","journal-title":"Indian J Psychiatry."},{"key":"B160","doi-asserted-by":"publisher","first-page":"247150","DOI":"10.1155\/2012\/247150","article-title":"Synapses and dendritic spines as pathogenic targets in Alzheimer's disease","volume":"2012","author":"Yu","year":"2012","journal-title":"Neural Plast."},{"key":"B161","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/j.neurobiolaging.2007.02.029","article-title":"Alzheimer's disease-type neuronal tau hyperphosphorylation induced by A beta oligomers","volume":"29","author":"De Felice","year":"2008","journal-title":"Neurobiol Aging."},{"key":"B162","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3233\/JAD-2009-0960","article-title":"Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer's disease","volume":"16","author":"Huang","year":"2009","journal-title":"J Alzheimers Dis."},{"key":"B163","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00401-014-1328-5","article-title":"Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer's disease and tauopathies","volume":"128","author":"Yarchoan","year":"2014","journal-title":"Acta Neuropathol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neuron.2018.06.003","article-title":"Dendritic tau in Alzheimer's disease","volume":"99","author":"Ittner","year":"2018","journal-title":"Neuron."},{"key":"B165","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1073\/pnas.96.6.3228","article-title":"Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models","volume":"96","author":"Hsia","year":"1999","journal-title":"Proc Natl Acad Sci USA."},{"key":"B166","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0006-8993(99)01698-4","article-title":"Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice","volume":"840","author":"Larson","year":"1999","journal-title":"Brain Res."},{"key":"B167","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1111\/j.1471-4159.2006.04426.x","article-title":"A beta oligomers - a decade of discovery","volume":"101","author":"Walsh","year":"2007","journal-title":"J Neurochem."},{"key":"B168","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1471-4159.2011.07506.x","article-title":"Amyloid beta: linking synaptic plasticity failure to memory disruption in Alzheimer's disease","volume":"120","author":"Ma","year":"2012","journal-title":"J Neurochem."},{"key":"B169","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.nbd.2013.03.004","article-title":"Deleterious effects of soluble amyloid-beta oligomers on multiple steps of synaptic vesicle trafficking","volume":"55","author":"Park","year":"2013","journal-title":"Neurobiol Dis."},{"key":"B170","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1126\/science.aay0198","article-title":"A vicious cycle of beta amyloid-dependent neuronal hyperactivation","volume":"365","author":"Zott","year":"2019","journal-title":"Science."},{"key":"B171","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nrn2967","article-title":"Amyloid-beta and tau\u2013a toxic pas de deux in Alzheimer's disease","volume":"12","author":"Ittner","year":"2011","journal-title":"Nat Rev Neurosci."},{"key":"B172","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","article-title":"Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration","volume":"68","author":"Hoover","year":"2010","journal-title":"Neuron."},{"key":"B173","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","article-title":"A\u03b2 oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease","volume":"27","author":"Lacor","year":"2007","journal-title":"J Neurosci."},{"key":"B174","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3233\/JAD-2006-9S311","article-title":"Synaptic remodeling during aging and in Alzheimer's disease","volume":"9","author":"Masliah","year":"2006","journal-title":"J Alzheimers Dis."},{"key":"B175","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.exger.2006.08.009","article-title":"The role of insulin and neurotrophic factor signaling in brain aging and Alzheimer's Disease","volume":"42","author":"Cole","year":"2007","journal-title":"Exp Gerontol."},{"key":"B176","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.neuropharm.2017.11.014","article-title":"Connecting Alzheimer's disease to diabetes: underlying mechanisms and potential therapeutic targets","volume":"136","author":"Vieira","year":"2018","journal-title":"Neuropharmacology."},{"key":"B177","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1007\/s12640-017-9809-7","article-title":"Intranasal insulin ameliorates cerebral hypometabolism, neuronal loss, and astrogliosis in streptozotocin-induced Alzheimer's rat model","volume":"33","author":"Chen","year":"2018","journal-title":"Neurotox Res."},{"key":"B178","doi-asserted-by":"publisher","first-page":"6507","DOI":"10.1007\/s12035-016-0169-8","article-title":"Intranasal insulin administration ameliorates streptozotocin (ICV)-induced insulin receptor dysfunction, neuroinflammation, amyloidogenesis, and memory impairment in rats","volume":"54","author":"Rajasekar","year":"2017","journal-title":"Mol Neurobiol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3233\/JAD-141791","article-title":"Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia","volume":"44","author":"Claxton","year":"2015","journal-title":"J Alzheimers Dis."},{"key":"B180","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1001\/archneurol.2011.233","article-title":"Intranasal insulin therapy for alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial","volume":"69","author":"Craft","year":"2012","journal-title":"Arch Neurol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3233\/JAD-2008-13309","article-title":"Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults","volume":"13","author":"Reger","year":"2008","journal-title":"J Alzheimers Dis."},{"key":"B182","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/cc9098","article-title":"Bench-to-bedside review: targeting antioxidants to mitochondria in sepsis","volume":"14","author":"Galley","year":"2010","journal-title":"Crit Care."},{"key":"B183","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.redox.2013.04.005","article-title":"Sites of reactive oxygen species generation by mitochondria oxidizing different substrates","volume":"1","author":"Quinlan","year":"2013","journal-title":"Redox Biol."},{"key":"B184","doi-asserted-by":"publisher","first-page":"113114","DOI":"10.1016\/j.expneurol.2019.113114","article-title":"Therapeutic use of extracellular mitochondria in CNS injury and disease","volume":"324","author":"Nakamura","year":"2020","journal-title":"Exp Neurol."},{"key":"B185","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3389\/fnagi.2019.00236","article-title":"The involvement of peripheral and brain insulin resistance in late onset Alzheimer's dementia","volume":"11","author":"Folch","year":"2019","journal-title":"Front Aging Neurosci."},{"key":"B186","doi-asserted-by":"publisher","first-page":"104772","DOI":"10.1016\/j.nbd.2020.104772","article-title":"Brain insulin resistance triggers early onset alzheimer disease in down syndrome","volume":"137","author":"Tramutola","year":"2020","journal-title":"Neurobiol Dis."},{"key":"B187","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.2337\/db13-1751","article-title":"Mitochondria-associated endoplasmic reticulum membrane (MAM) integrity is required for insulin signaling and is implicated in hepatic insulin resistance","volume":"63","author":"Tubbs","year":"2014","journal-title":"Diabetes."},{"key":"B188","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.bbagen.2009.04.005","article-title":"PGC-1alpha in aging and anti-aging interventions","volume":"1790","author":"Anderson","year":"2009","journal-title":"Biochim Biophys Acta."},{"key":"B189","doi-asserted-by":"publisher","first-page":"22464","DOI":"10.1074\/jbc.M800842200","article-title":"PGC-1alpha integrates insulin signaling, mitochondrial regulation, and bioenergetic function in skeletal muscle","volume":"283","author":"Pagel-Langenickel","year":"2008","journal-title":"J Biol Chem."},{"key":"B190","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell."},{"key":"B191","doi-asserted-by":"publisher","first-page":"NP544","DOI":"10.1177\/1010539513477685","article-title":"Relationship of PGC-1alpha gene polymorphism with insulin resistance syndrome in Korean children","volume":"27","author":"Ha","year":"2015","journal-title":"Asia Pac J Public Health."},{"key":"B192","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1001\/archneurol.2008.588","article-title":"PGC-1alpha expression decreases in the alzheimer disease brain as a function of dementia","volume":"66","author":"Qin","year":"2009","journal-title":"Arch Neurol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5115\/acb.2016.49.1.1","article-title":"The association between PGC-1alpha and Alzheimer's disease","volume":"49","author":"Sweeney","year":"2016","journal-title":"Anat Cell Biol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1111\/epi.12731","article-title":"Cerebral glucose hypometabolism is associated with mitochondrial dysfunction in patients with intractable epilepsy and cortical dysplasia","volume":"55","author":"Tenney","year":"2014","journal-title":"Epilepsia."},{"key":"B195","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.neuron.2015.03.035","article-title":"A cellular perspective on brain energy metabolism and functional imaging","volume":"86","author":"Magistretti","year":"2015","journal-title":"Neuron."},{"key":"B196","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.3233\/JAD-190048","article-title":"Molecular basis of Alzheimer's disease: focus on mitochondria","volume":"72","author":"Oliver","year":"2019","journal-title":"J Alzheimers Dis."},{"key":"B197","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s11892-014-0476-2","article-title":"Alzheimer's disease and type 2 diabetes: multiple mechanisms contribute to interactions","volume":"14","author":"Jayaraman","year":"2014","journal-title":"Curr Diab Rep."},{"key":"B198","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/13543784.2020.1738383","article-title":"Brain insulin resistance: role in neurodegenerative disease and potential for targeting","volume":"29","author":"Holscher","year":"2020","journal-title":"Expert Opin Investig Drugs."},{"key":"B199","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nrn.2017.170","article-title":"Mitochondria at the neuronal presynapse in health and disease","volume":"19","author":"Devine","year":"2018","journal-title":"Nat Rev Neurosci."},{"key":"B200","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1179\/016164103101201977","article-title":"Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and alzheimer disease-like pathology in transgenic mice","volume":"25","author":"Aliev","year":"2003","journal-title":"Neurol Res."},{"key":"B201","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3389\/fphar.2019.00902","article-title":"Mitochondria as potential targets in alzheimer disease therapy: an update","volume":"10","author":"Cenini","year":"2019","journal-title":"Front Pharmacol."},{"key":"B202","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.biopha.2015.07.025","article-title":"Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight","volume":"74","author":"Bhat","year":"2015","journal-title":"Biomed Pharmacother."},{"key":"B203","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1124\/jpet.112.192138","article-title":"Mitochondrial dysfunction in neurodegenerative diseases","volume":"342","author":"Johri","year":"2012","journal-title":"J Pharmacol Exp Ther."},{"key":"B204","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3233\/JAD-2006-9204","article-title":"Mitochondrial alterations in Alzheimer's disease","volume":"9","author":"Baloyannis","year":"2006","journal-title":"J Alzheimers Dis."},{"key":"B205","doi-asserted-by":"publisher","first-page":"19318","DOI":"10.1073\/pnas.0804871105","article-title":"Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission\/fusion proteins","volume":"105","author":"Wang","year":"2008","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B206","doi-asserted-by":"publisher","first-page":"9090","DOI":"10.1523\/JNEUROSCI.1357-09.2009","article-title":"Impaired balance of mitochondrial fission and fusion in Alzheimer's disease","volume":"29","author":"Wang","year":"2009","journal-title":"J Neurosci."},{"key":"B207","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fnmol.2016.00053","article-title":"Can ketones help rescue brain fuel supply in later life? Implications for cognitive health during aging and the treatment of Alzheimer's disease","volume":"9","author":"Cunnane","year":"2016","journal-title":"Front Mol Neurosci."},{"key":"B208","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1196\/annals.1427.007","article-title":"Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease","volume":"1147","author":"Mosconi","year":"2008","journal-title":"Ann N Y Acad Sci."},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1101\/2019.12.23.887364","article-title":"Transcriptomic analysis of brain hypometabolism links the cholinergic and gingipain hypotheses of Alzheimer's disease pathogenesis","author":"Patel","year":"2020","journal-title":"bioRxiv [Preprint]"},{"key":"B210","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1002\/jnr.24064","article-title":"The vicious circle of hypometabolism in neurodegenerative diseases: ways and mechanisms of metabolic correction","volume":"95","author":"Zilberter","year":"2017","journal-title":"J Neurosci Res."},{"key":"B211","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0047-6374(80)90120-7","article-title":"Glycolytic enzymes from human autoptic brain cortex: normal aged and demented cases","volume":"14","author":"Iwangoff","year":"1980","journal-title":"Mech Ageing Dev."},{"key":"B212","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.nut.2010.07.021","article-title":"Brain fuel metabolism, aging, and Alzheimer's disease","volume":"27","author":"Cunnane","year":"2011","journal-title":"Nutrition."},{"key":"B213","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00259-014-2919-z","article-title":"Cortical hypermetabolism in MCI subjects: a compensatory mechanism?","volume":"42","author":"Ashraf","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B214","doi-asserted-by":"publisher","first-page":"102054","DOI":"10.1155\/2015\/102054","article-title":"Plasma lactate levels increase during hyperinsulinemic euglycemic clamp and oral glucose tolerance test","volume":"2015","author":"Berhane","year":"2015","journal-title":"J Diabetes Res."},{"key":"B215","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","article-title":"Brain insulin resistance in type 2 diabetes and alzheimer disease: concepts and conundrums","volume":"14","author":"Arnold","year":"2018","journal-title":"Nat Rev Neurol."},{"key":"B216","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3390\/brainsci9100262","article-title":"Type 2 diabetes mellitus increases the risk of late-onset Alzheimer's disease: ultrastructural remodeling of the neurovascular unit and diabetic gliopathy","volume":"9","author":"Hayden","year":"2019","journal-title":"Brain Sci."},{"key":"B217","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1210\/jc.2015-2318","article-title":"White matter microstructure and cognitive function in young women with polycystic ovary syndrome","volume":"101","author":"Rees","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"key":"B218","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.2337\/dc11-0308","article-title":"Association of metabolic dysregulation with volumetric brain magnetic resonance imaging and cognitive markers of subclinical brain aging in middle-aged adults: the framingham offspring study","volume":"34","author":"Tan","year":"2011","journal-title":"Diabetes Care."},{"key":"B219","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2967\/jnumed.113.132647","article-title":"Diabetes and elevated hemoglobin A1c levels are associated with brain hypometabolism but not amyloid accumulation","volume":"55","author":"Roberts","year":"2014","journal-title":"J Nucl Med."},{"key":"B220","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1523\/JNEUROSCI.3131-15.2016","article-title":"Aerobic glycolysis in the frontal cortex correlates with memory performance in wild-type mice but not the APP\/PS1 mouse model of cerebral amyloidosis","volume":"36","author":"Harris","year":"2016","journal-title":"J Neurosci."},{"key":"B221","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/nn.4018","article-title":"Three dimensions of the amyloid hypothesis: time, space and 'wingmen'","volume":"18","author":"Musiek","year":"2015","journal-title":"Nat Neurosci."},{"key":"B222","doi-asserted-by":"publisher","first-page":"14670","DOI":"10.1073\/pnas.0903563106","article-title":"Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease","volume":"106","author":"Yao","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B223","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0304-3940(97)00741-6","article-title":"Oxidative metabolism in cultured fibroblasts derived from sporadic Alzheimer's disease (AD) patients","volume":"236","author":"Curti","year":"1997","journal-title":"Neurosci Lett."},{"key":"B224","doi-asserted-by":"publisher","first-page":"384017","DOI":"10.1155\/2012\/384017","article-title":"Insulin in central nervous system: more than just a peripheral hormone","volume":"2012","author":"Duarte","year":"2012","journal-title":"J Aging Res."},{"key":"B225","doi-asserted-by":"publisher","first-page":"470","DOI":"10.2353\/ajpath.2008.071208","article-title":"Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer's disease patients","volume":"173","author":"Wang","year":"2008","journal-title":"Am J Pathol."},{"key":"B226","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3233\/JAD-170585","article-title":"Mitochondria and mitochondrial cascades in Alzheimer's disease","volume":"62","author":"Swerdlow","year":"2018","journal-title":"J Alzheimers Dis."},{"key":"B227","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s12035-012-8245-1","article-title":"Primary skin fibroblasts as a model of parkinson's disease","volume":"46","author":"Auburger","year":"2012","journal-title":"Mol Neurobiol."},{"key":"B228","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1023\/B:JOBB.0000041764.45552.f3","article-title":"Mitochondrial enzymes and endoplasmic reticulum calcium stores as targets of oxidative stress in neurodegenerative diseases","volume":"36","author":"Gibson","year":"2004","journal-title":"J Bioenerg Biomembr."},{"key":"B229","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/ana.20474","article-title":"Mitochondrial abnormalities in alzheimer brain: mechanistic implications","volume":"57","author":"Bubber","year":"2005","journal-title":"Ann Neurol."},{"key":"B230","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0197-4580(00)00112-3","article-title":"A selective defect of cytochrome c oxidase is present in brain of alzheimer disease patients","volume":"21","author":"Maurer","year":"2000","journal-title":"Neurobiol Aging."},{"key":"B231","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/hmg\/ddh140","article-title":"Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease","volume":"13","author":"Reddy","year":"2004","journal-title":"Hum Mol Genet."},{"key":"B232","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neurobiolaging.2016.12.029","article-title":"Mitochondrial genes are altered in blood early in Alzheimer's disease","volume":"53","author":"Lunnon","year":"2017","journal-title":"Neurobiol Aging."},{"key":"B233","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.2337\/db11-1186","article-title":"Metabolic alterations induced by sucrose intake and Alzheimer's disease promote similar brain mitochondrial abnormalities","volume":"61","author":"Carvalho","year":"2012","journal-title":"Diabetes."},{"key":"B234","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3233\/JAD-141890","article-title":"Characterization of ATP alternations in an Alzheimer's disease transgenic mouse model","volume":"44","author":"Zhang","year":"2015","journal-title":"J Alzheimers Dis."},{"key":"B235","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.yexcr.2015.01.004","article-title":"Regulation of mitochondrial transport in neurons","volume":"334","author":"Lin","year":"2015","journal-title":"Exp Cell Res."},{"key":"B236","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.mcn.2019.06.009","article-title":"Mitochondrial dynamics and transport in Alzheimer's disease","volume":"98","author":"Flannery","year":"2019","journal-title":"Mol Cell Neurosci."},{"key":"B237","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1093\/hmg\/ddr139","article-title":"Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage","volume":"20","author":"Manczak","year":"2011","journal-title":"Hum Mol Genet."},{"key":"B238","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3934\/molsci.2015.2.161","article-title":"Mitochondrial dynamics in neurodegeneration: from cell death to energetic states","volume":"2","author":"Khacho","year":"2015","journal-title":"AIMS Mol Sci."},{"key":"B239","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40035-018-0107-y","article-title":"Alzheimer's disease hypothesis and related therapies","volume":"7","author":"Du","year":"2018","journal-title":"Transl Neurodegener."},{"key":"B240","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3389\/fnagi.2019.00311","article-title":"Dysfunctional mitochondria and mitophagy as drivers of Alzheimer's disease pathogenesis","volume":"11","author":"Chakravorty","year":"2019","journal-title":"Front Aging Neurosci."},{"key":"B241","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.bbadis.2013.08.013","article-title":"March separate, strike together\u2013role of phosphorylated TAU in mitochondrial dysfunction in Alzheimer's disease","volume":"1842","author":"Eckert","year":"2014","journal-title":"Biochim Biophys Acta."},{"key":"B242","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s12035-012-8308-3","article-title":"A new link to mitochondrial impairment in tauopathies","volume":"46","author":"Schulz","year":"2012","journal-title":"Mol Neurobiol."},{"key":"B243","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1016\/j.ajpath.2011.07.004","article-title":"Tau accumulation causes mitochondrial distribution deficits in neurons in a mouse model of tauopathy and in human Alzheimer's disease brain","volume":"179","author":"Kopeikina","year":"2011","journal-title":"Am J Pathol."},{"key":"B244","doi-asserted-by":"publisher","first-page":"20057","DOI":"10.1073\/pnas.0905529106","article-title":"Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice","volume":"106","author":"Rhein","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B245","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.expneurol.2009.01.011","article-title":"The Alzheimer's disease mitochondrial cascade hypothesis: an update","volume":"218","author":"Swerdlow","year":"2009","journal-title":"Exp Neurol."},{"key":"B246","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.3389\/fnins.2019.01444","article-title":"Interplay between mitochondrial oxidative disorders and proteostasis in Alzheimer's disease","volume":"13","author":"Llanos-Gonzalez","year":"2019","journal-title":"Front Neurosci."},{"key":"B247","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/1479-7364-4-3-170","article-title":"Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes","volume":"4","author":"Mosconi","year":"2010","journal-title":"Hum Genomics."},{"key":"B248","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3233\/JAD-2011-110866","article-title":"Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer's disease","volume":"27","author":"Mosconi","year":"2011","journal-title":"J Alzheimers Dis."},{"key":"B249","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/hmg\/ddl066","article-title":"Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression","volume":"15","author":"Manczak","year":"2006","journal-title":"Hum Mol Genet."},{"key":"B250","doi-asserted-by":"publisher","first-page":"9302761","DOI":"10.1155\/2017\/9302761","article-title":"Slower dynamics and aged mitochondria in sporadic Alzheimer's disease","volume":"2017","author":"Martin-Maestro","year":"2017","journal-title":"Oxid Med Cell Longev."},{"key":"B251","doi-asserted-by":"publisher","first-page":"R169","DOI":"10.1093\/hmg\/ddp326","article-title":"Mitochondrial dynamics\u2013fusion, fission, movement, and mitophagy\u2013in neurodegenerative diseases","volume":"18","author":"Chen","year":"2009","journal-title":"Hum Mol Genet."},{"key":"B252","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3390\/cells9040815","article-title":"Redox modifications of proteins of the mitochondrial fusion and fission machinery","volume":"9","author":"Wolf","year":"2020","journal-title":"Cells."},{"key":"B253","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1093\/hmg\/ddt247","article-title":"Bioenergetic flux, mitochondrial mass and mitochondrial morphology dynamics in AD and MCI cybrid cell lines","volume":"22","author":"Silva","year":"2013","journal-title":"Hum Mol Genet."},{"key":"B254","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/bs.pmbts.2016.12.017","article-title":"Mitochondria, cybrids, aging, and Alzheimer's disease","volume":"146","author":"Swerdlow","year":"2017","journal-title":"Prog Mol Biol Transl Sci."},{"key":"B255","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.tins.2017.01.002","article-title":"Mitophagy and Alzheimer's disease: cellular and molecular mechanisms","volume":"40","author":"Kerr","year":"2017","journal-title":"Trends Neurosci."},{"key":"B256","doi-asserted-by":"publisher","first-page":"8094","DOI":"10.1002\/jcp.27588","article-title":"Autophagic dysfunction in Alzheimer's disease: cellular and molecular mechanistic approaches to halt Alzheimer's pathogenesis","volume":"234","author":"Uddin","year":"2019","journal-title":"J Cell Physiol."},{"key":"B257","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3390\/cells8050488","article-title":"Amyloid Beta and phosphorylated tau-induced defective autophagy and mitophagy in Alzheimer's disease","volume":"8","author":"Reddy","year":"2019","journal-title":"Cells."},{"key":"B258","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1093\/hmg\/ddv616","article-title":"PARK2 enhancement is able to compensate mitophagy alterations found in sporadic Alzheimer's disease","volume":"25","author":"Martin-Maestro","year":"2016","journal-title":"Hum Mol Genet."},{"key":"B259","doi-asserted-by":"publisher","first-page":"925050","DOI":"10.4061\/2011\/925050","article-title":"Amyloid-beta interaction with mitochondria","volume":"2011","author":"Pagani","year":"2011","journal-title":"Int J Alzheimers Dis."},{"key":"B260","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.toxlet.2017.10.021","article-title":"Resveratrol attenuates oxidative damage through activating mitophagy in an in vitro model of Alzheimer's disease","volume":"282","author":"Wang","year":"2018","journal-title":"Toxicol Lett."},{"key":"B261","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.bbrc.2015.09.137","article-title":"Maternal diabetes triggers DNA damage and DNA damage response in neurulation stage embryos through oxidative stress","volume":"467","author":"Dong","year":"2015","journal-title":"Biochem Biophys Res Commun."},{"key":"B262","doi-asserted-by":"publisher","first-page":"471","DOI":"10.18632\/aging.100189","article-title":"p53, ROS and senescence in the control of aging","volume":"2","author":"Vigneron","year":"2010","journal-title":"Aging."},{"key":"B263","first-page":"982","article-title":"Insulin resistance and mitochondrial dysfunction","volume-title":"Mitochondrial Dynamics in Cardiovascular Medicine Advances in Experimental Medicine and Biology","author":"Gonzalez-Franquesa","year":"2017"},{"key":"B264","doi-asserted-by":"publisher","first-page":"4887","DOI":"10.1007\/s00018-019-03148-8","article-title":"Proinflammatory NFkB signalling promotes mitochondrial dysfunction in skeletal muscle in response to cellular fuel overloading","volume":"76","author":"Nisr","year":"2019","journal-title":"Cell Mol Life Sci."},{"key":"B265","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jns.2018.09.033","article-title":"Mitochondrial therapeutic interventions in Alzheimer's disease","volume":"395","author":"Van Giau","year":"2018","journal-title":"J Neurol Sci."},{"key":"B266","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s12264-013-1424-x","article-title":"Neuronal failure in Alzheimer's disease: a view through the oxidative stress looking-glass","volume":"30","author":"Bonda","year":"2014","journal-title":"Neurosci Bull."},{"key":"B267","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.bbadis.2013.10.015","article-title":"Oxidative stress and mitochondrial dysfunction in Alzheimer's disease","volume":"1842","author":"Wang","year":"2014","journal-title":"Biochim Biophys Acta."},{"key":"B268","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-020-00197-z","article-title":"Mitochondria as a target for neuroprotection: role of methylene blue and photobiomodulation","volume":"9","author":"Yang","year":"2020","journal-title":"Transl Neurodegener."},{"key":"B269","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.bbadis.2016.11.010","article-title":"Mitochondrial dysfunction and oxidative stress in metabolic disorders - A step towards mitochondria based therapeutic strategies","volume":"1863","author":"Bhatti","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"key":"B270","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3389\/fphys.2014.00512","article-title":"Mitochondrial efficiency and insulin resistance","volume":"5","author":"Crescenzo","year":"2014","journal-title":"Front Physiol."},{"key":"B271","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1089\/rej.2017.1989","article-title":"Circulating mitochondrial DNA at the crossroads of mitochondrial dysfunction and inflammation during aging and muscle wasting disorders","volume":"21","author":"Picca","year":"2018","journal-title":"Rejuvenation Res."},{"key":"B272","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1749-6632.2010.05625.x","article-title":"Mitochondrial dysfunction in insulin insensitivity: implication of mitochondrial role in type 2 diabetes","volume":"1201","author":"Wang","year":"2010","journal-title":"Ann N Y Acad Sci."},{"key":"B273","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1471-4159.2005.03530.x","article-title":"Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease","volume":"96","author":"Reddy","year":"2006","journal-title":"J Neurochem."},{"key":"B274","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1089\/ars.2007.1754","article-title":"Mitochondrial dysfunction in aging and Alzheimer's disease: strategies to protect neurons","volume":"9","author":"Reddy","year":"2007","journal-title":"Antioxid Redox Signal."},{"key":"B275","doi-asserted-by":"publisher","first-page":"849","DOI":"10.2174\/1568026615666150827095102","article-title":"Relationships between mitochondria and neuroinflammation: implications for Alzheimer's disease","volume":"16","author":"Wilkins","year":"2016","journal-title":"Curr Top Med Chem."},{"key":"B276","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0197-0186(99)00114-X","article-title":"The alpha-ketoglutarate dehydrogenase complex in neurodegeneration","volume":"36","author":"Gibson","year":"2000","journal-title":"Neurochem Int."},{"key":"B277","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1749-6632.1997.tb48473.x","article-title":"Brain energy metabolizing enzymes in Alzheimer's disease: alpha-ketoglutarate dehydrogenase complex and cytochrome oxidase","volume":"826","author":"Kish","year":"1997","journal-title":"Ann N Y Acad Sci."},{"key":"B278","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1089\/ars.2007.1703","article-title":"Alzheimer's disease: a lesson from mitochondrial dysfunction","volume":"9","author":"Moreira","year":"2007","journal-title":"Antioxid Redox Signal."},{"key":"B279","doi-asserted-by":"publisher","first-page":"104545","DOI":"10.4061\/2011\/104545","article-title":"Mitochondria, amyloid beta, and Alzheimer's disease","volume":"2011","author":"Readnower","year":"2011","journal-title":"Int J Alzheimers Dis."},{"key":"B280","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1385\/NMM:5:2:147","article-title":"Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage","volume":"5","author":"Manczak","year":"2004","journal-title":"Neuromolecular Med."},{"key":"B281","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pneurobio.2013.06.004","article-title":"Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies","volume":"108","author":"Chen","year":"2013","journal-title":"Prog Neurobiol."},{"key":"B282","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40035-019-0158-8","article-title":"Current progress of mitochondrial transplantation that promotes neuronal regeneration","volume":"8","author":"Chang","year":"2019","journal-title":"Transl Neurodegener."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2020.560375\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T05:56:59Z","timestamp":1604555819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2020.560375\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,5]]},"references-count":282,"alternative-id":["10.3389\/fendo.2020.560375"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.560375","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,5]]},"article-number":"560375"}}